Skip to main content
Future Medicine Co., Ltd. logo

Future Medicine Co., Ltd. — Investor Relations & Filings

Ticker · 341170 ISIN · KR7341170009 KO Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2024-03-13 AGM Information
Country KR South Korea
Listing KO 341170

About Future Medicine Co., Ltd.

http://futuremedicine.co.kr/

Future Medicine Co., Ltd. is a new drug development company specializing in nucleoside-based synthetic drugs. The company focuses on creating therapeutics for diseases with high unmet medical needs, particularly in antiviral and anticancer applications. Its primary pipeline candidate, FM101, is an anti-inflammatory and anti-fibrotic agent being investigated for the treatment of conditions such as non-alcoholic steatohepatitis (NASH), diabetic nephropathy, and primary biliary cholangitis (PBC). The company has also conducted research and filed patents for therapeutics related to coronaviruses.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with other companies' meetings, which is a specific regulatory disclosure requirement in the Korean market. Since it does not fit into the specific categories of AGM materials, proxy statements, or voting results, and is a standard regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2024-03-13 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory notice regarding the setting of a record date and shareholder register closure period for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notification of the meeting's administrative preparation. Given the nature of the announcement and the lack of a specific category for 'Record Date/Shareholder Register' notices, it falls under the general regulatory filing category.
2023-12-15 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 1% confidence The document is a short, structured announcement detailing the results of an Investor Relations (IR) event held by Future Medicine. It lists the date, location, attendees, and agenda of the meeting, and provides a link/reference to where the actual IR materials are posted. Per the 'Menu vs Meal' rule, since this is a short announcement of an event and refers to the availability of materials elsewhere rather than being the presentation itself, it is classified as a Report Publication Announcement (RPA).
2023-11-23 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal notice announcing the scheduling and details of an upcoming Investor Relations (IR) event (기업설명회). It specifies the date, location, target audience, and purpose of the meeting. Since this is an announcement of an event rather than the presentation materials themselves or a financial report, it falls under the category of a regulatory filing announcing corporate activity.
2023-11-09 Korean
기타주요경영사항(자율공시)(코스닥시장 상장을 위한 상장예비심사 신청)
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement (585 characters) regarding the submission of a preliminary application for listing on the KOSDAQ market. It does not contain full financial statements or detailed reports, but rather serves as a formal notification of a corporate action (listing application). As it is a regulatory announcement that does not fit into specific categories like M&A or dividend notices, it is classified as a general regulatory filing.
2023-10-20 Korean
이전상장결정
Delisting Announcement Classification · 1% confidence The document is a regulatory filing from the Korean stock market (KOSDAQ) regarding a company's decision to transfer its listing (이전상장). It details the board resolution date, the reason for the transfer, and the schedule. Since this is a specific regulatory announcement regarding corporate structure/listing status that does not fit into categories like M&A, share issuance, or financial reporting, it is classified as a general regulatory filing.
2023-10-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.